Clinical Trials Logo

Clinical Trial Summary

This trial is being completed to evaluate the safety and efficacy of topical tranexamic acid use in preventing hematomas in routine breast plastic surgery operations.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05441592
Study type Interventional
Source University of Michigan
Contact Sherry Tang, MD
Phone 734-936-5895
Email syqtang@med.umich.edu
Status Recruiting
Phase Phase 4
Start date August 15, 2022
Completion date June 2024

See also
  Status Clinical Trial Phase
Recruiting NCT03738527 - SEroma Reduction pOst MAstectomy "SEROMA Study" Phase 4
Completed NCT04947514 - Use of Tranexamic Acid in Reduction Mammoplasty Phase 4
Not yet recruiting NCT04389398 - Prevention of Pocket Hematoma After Implantation Cardiovascular Implanted Electronic Devices N/A
Completed NCT04559646 - Application of the "Haemoblock" in Pacemaker Patients
Recruiting NCT03535116 - The Effect of Intra-operative Ketorolac on Hematoma Rates in Breast Reduction Surgery Phase 4
Not yet recruiting NCT04918576 - Topical Tranexamic Acid for Bilateral Breast Reduction Surgery Phase 3
Not yet recruiting NCT04918589 - Tranexamic Acid for Alloplastic Breast Reconstruction Phase 3
Active, not recruiting NCT04554407 - Study to Evaluate the Performance of a Sustained Vacuum System N/A